CORT
CORCEPT THERAPEUTICS INCCompany Information
- Company Name
- CORCEPT THERAPEUTICS INC
- CIK
- CIK0001088856
- Category
- Large accelerated filer
- Ticker: Exchange
- CORT: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CORT
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-03-17
- Last sale
- 2026-09-16
- Shares purchased (TTM)
- 100,000
- Shares sold (TTM)
- 1,170,932
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 74,246,223
- Shares outstanding
- 105,377,000
- Ownership
- 70.46%
Earnings Market Reaction
- Filing date
- 2026-07-29
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 111 | 109 | 120 | 125 | 103 | 90 | 128 | 137 | 129 | 150 | 136 | 112 | ||||||
| Marketable Securities Current | 197 | 229 | 252 | 297 | 239 | 233 | 256 | 243 | 345 | 261 | 233 | 243 | ||||||
| Accounts Receivable Net Current | 77 | 39 | 60 | 70 | 65 | 62 | 54 | 60 | 54 | 62 | 41 | 35 | ||||||
| Inventory Net | 13 | 13 | 13 | 12 | 12 | 14 | 12 | 8 | 8 | 7 | 8 | 8 | ||||||
| Loss Contingency Receivable Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 14 | 14 | ||||||
| Prepaid Expense And Other Assets Current | 41 | 36 | 41 | 37 | 24 | 40 | 22 | 19 | 26 | 24 | 28 | 20 | ||||||
| Assets Current | 440 | 426 | 485 | 541 | 443 | 439 | 472 | 467 | 561 | 503 | 459 | 432 | ||||||
| Inventory Noncurrent | 19 | 15 | 11 | 12 | 8 | 1 | 4 | 8 | 8 | 8 | 8 | 9 | ||||||
| Operating Lease Right Of Use Asset | 7 | 7 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 5 | 3 | 2 | 2 | 2 | 3 | 3 | 3 | 1 | 0 | 0 | 0 | ||||||
| Marketable Securities Noncurrent | 236 | 177 | 160 | 103 | 173 | 248 | 220 | 167 | 19 | 40 | 57 | 60 | ||||||
| Other Assets Noncurrent | 3 | 5 | 5 | 8 | 8 | 7 | 7 | 7 | 7 | 6 | 7 | 7 | ||||||
| Deferred Income Tax Assets Net | 179 | 182 | 168 | 153 | 162 | 144 | 131 | 127 | 112 | 98 | 91 | 87 | ||||||
| Assets | 889 | 815 | 837 | 824 | 802 | 846 | 841 | 784 | 715 | 656 | 622 | 594 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 15 | 33 | 40 | 34 | 24 | 28 | 15 | 19 | 19 | 13 | 17 | 17 | ||||||
| Accrued Liabilities Current | 115 | 80 | 91 | 108 | 91 | 89 | 91 | 79 | 59 | 60 | 52 | 70 | ||||||
| Operating Lease Liability Current | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 154 | 149 | 166 | 172 | 145 | 143 | 141 | 126 | 101 | 97 | 105 | 122 | ||||||
| Loss Contingency Accrual Carrying Value Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 14 | 14 | ||||||
| Operating Lease Liability Noncurrent | 8 | 8 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | - | 0 | - | ||||||
| Accrued Income Taxes Noncurrent | 15 | 15 | 15 | 14 | 16 | 14 | 14 | 13 | 12 | 11 | 10 | 10 | ||||||
| Liabilities | 183 | 177 | 189 | 192 | 166 | 163 | 161 | 145 | 118 | 108 | 115 | 132 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value Outstanding | - | 0 | - | - | - | 0 | 0 | - | - | 0 | 0 | - | ||||||
| Preferred Stock Value | 0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 | - | - | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Common Value | -998 | -977 | -967 | -923 | -867 | -745 | -696 | -682 | -651 | -641 | -635 | -632 | ||||||
| Additional Paid In Capital Common Stock | 1,049 | 1,002 | 969 | 934 | 901 | 863 | 832 | 806 | 781 | 758 | 739 | 722 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 1 | 2 | 2 | 2 | 1 | -0 | 2 | 0 | 0 | 1 | -0 | ||||||
| Retained Earnings Accumulated Deficit | 655 | 612 | 643 | 619 | 599 | 564 | 544 | 513 | 466 | 430 | 403 | 371 | ||||||
| Stockholders Equity | 706 | 638 | 648 | 632 | 636 | 683 | 680 | 639 | 596 | 548 | 507 | 462 | ||||||
| Liabilities And Stockholders Equity | 889 | 815 | 837 | 824 | 802 | 846 | 841 | 784 | 715 | 656 | 622 | 594 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | 0.00 | - | - | - | 0.00 | - | - | - | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | - | - | 10 | - | - | - | 10 | - | - | - | 10 | - | ||||||
| Preferred Stock Shares Outstanding | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | - | - | 0.00 | - | - | - | 0.00 | - | - | - | 0.00 | - | ||||||
| Common Stock Shares Authorized | - | - | 280 | - | - | - | 280 | - | - | - | 280 | - | ||||||
| Common Stock Shares Issued | - | - | 143 | - | - | - | 138 | - | - | - | 134 | - | ||||||
| Shares Outstanding | - | - | 106 | - | - | - | 105 | - | - | - | 103 | - | ||||||
| Treasury Stock Common Shares | - | - | 37 | - | - | - | 33 | - | - | - | 31 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCORCEPT THERAPEUTICS INC (CORT) — SEC Financial Statements & Analysis
CORCEPT THERAPEUTICS INC (CORT) is a pharmaceutical preparations company, incorporated in DE. CORCEPT THERAPEUTICS INC trades on Nasdaq as: CORT. CORCEPT THERAPEUTICS INC (CORT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29. Based on that filing, CORCEPT THERAPEUTICS INC carries a market cap of $9.16B, a P/E ratio of 167.83x, a P/B ratio of 12.98x, a P/S ratio of 11.03x, an enterprise value of $9.05B, and an EV/EBITDA multiple of 1119.68x. On profitability, it posts a gross margin of 98.30%, an operating margin of 0.77%, a net margin of 6.57%, a Return on Equity (ROE) of 8.14%, a Return on Assets (ROA) of 6.46%, and a Return on Invested Capital (ROIC) of 0.00%. Per share, it reports EPS of $0.52, diluted EPS of $0.46, free cash flow per share of $1.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 16.02% year-over-year, net income growth of -59.07% year-over-year, and EPS growth of -59.56% year-over-year. On the balance sheet, it maintains a current ratio of 2.86x, a quick ratio of 2.50x, working capital of $285.87M, a debt-to-equity ratio of 0.26x, a debt ratio of 0.21, free cash flow of $106.92M (TTM), and net debt of $-111.04M. Figures sourced from SEC EDGAR.
- Market Cap
- $9.16B
- P/E TTM
- 167.83x
- EPS TTM
- $0.52
- P/B TTM
- 12.98x
- ROE TTM
- 8.14%
- ROA TTM
- 6.46%
- Debt To Equity
- 0.26x
- Free Cash Flow TTM
- $106.92M
- Net Revenue TTM Growth 1Y
- 16.02%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CORCEPT THERAPEUTICS INC in?
CORCEPT THERAPEUTICS INC (CORT) operates in the Pharmaceutical Preparations industry.
What exchange does CORT trade on?
CORCEPT THERAPEUTICS INC (CORT) trades on the Nasdaq.
Where is CORCEPT THERAPEUTICS INC incorporated?
CORCEPT THERAPEUTICS INC is incorporated in DE.
When was CORCEPT THERAPEUTICS INC (CORT)'s most recent SEC filing?
CORCEPT THERAPEUTICS INC (CORT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29.
What is CORT's market cap?
CORCEPT THERAPEUTICS INC (CORT) has a market capitalization of $9.16B as of 2026-06-30.
What is CORT's P/E ratio?
CORCEPT THERAPEUTICS INC (CORT)'s trailing twelve month P/E ratio is 167.83x as of 2026-06-30.
What is CORT's EPS (earnings per share)?
CORCEPT THERAPEUTICS INC (CORT)'s trailing twelve month EPS is $0.52 as of 2026-06-30.
What is CORT's ROE (return on equity)?
CORCEPT THERAPEUTICS INC (CORT)'s trailing twelve month Return on Equity (ROE) is 8.14% as of 2026-06-30.
What is CORT's ROA (return on assets)?
CORCEPT THERAPEUTICS INC (CORT)'s trailing twelve month Return on Assets (ROA) is 6.46% as of 2026-06-30.
What is CORT's ROIC (return on invested capital)?
CORCEPT THERAPEUTICS INC (CORT)'s trailing twelve month Return on Invested Capital (ROIC) is 0.00% as of 2026-06-30.
What is CORT's EV/EBITDA?
CORCEPT THERAPEUTICS INC (CORT)'s trailing twelve month EV/EBITDA is 1119.68x as of 2026-06-30.